Effects of sodium butyrate on human chronic myelogenous leukaemia cell line K562 - PubMed (original) (raw)

. 1979 Oct 25;281(5733):709-10.

doi: 10.1038/281709b0.

• PMID: 298333
• DOI: 10.1038/281709b0

Effects of sodium butyrate on human chronic myelogenous leukaemia cell line K562

C B Lozzio et al. Nature. 1979.

No abstract available

PubMed Disclaimer

Similar articles

• Induction of B-lymphocyte antigens on the chronic myeloid leukemic cell line K562 using sodium butyrate.
  Fraser JK, Berridge MV. Fraser JK, et al. Exp Hematol. 1987 May;15(4):406-13. Exp Hematol. 1987. PMID: 2952519
• New human myeloid leukaemia cell line undergoes red shift.
  Harrison PR. Harrison PR. Nature. 1979 Oct 25;281(5733):632-3. doi: 10.1038/281632b0. Nature. 1979. PMID: 298332 No abstract available.
• Involvement of Gialpha2 in sodium butyrate-induced erythroblastic differentiation of K562 cells.
  Davis MG, Kawai Y, Arinze IJ. Davis MG, et al. Biochem J. 2000 Mar 1;346 Pt 2(Pt 2):455-61. Biochem J. 2000. PMID: 10677366 Free PMC article.
• K562--a human leukemia cell line with erythroid features.
  Gahmberg CG, Andersson LC. Gahmberg CG, et al. Semin Hematol. 1981 Jan;18(1):72-7. Semin Hematol. 1981. PMID: 7010612 Review. No abstract available.
• Human leukaemic cell lines.
  Ferrero D, Rovera G. Ferrero D, et al. Clin Haematol. 1984 Jun;13(2):461-87. Clin Haematol. 1984. PMID: 6088146 Review. No abstract available.

Cited by

• Characterization of K562 cells: uncovering novel chromosomes, assessing transferrin receptor expression, and probing pharmacological therapies.
  Karagiannis TC, Wall M, Ververis K, Pitsillou E, Tortorella SM, Wood PA, Rafehi H, Khurana I, Maxwell SS, Hung A, Vongsvivut J, El-Osta A. Karagiannis TC, et al. Cell Mol Life Sci. 2023 Aug 14;80(9):248. doi: 10.1007/s00018-023-04905-6. Cell Mol Life Sci. 2023. PMID: 37578596 Free PMC article.
• Mutation or not, what directly establishes a neoplastic state, namely cellular immortality and autonomy, still remains unknown and should be prioritized in our research.
  Zhu S, Wang J, Zellmer L, Xu N, Liu M, Hu Y, Ma H, Deng F, Yang W, Liao DJ. Zhu S, et al. J Cancer. 2022 Jul 4;13(9):2810-2843. doi: 10.7150/jca.72628. eCollection 2022. J Cancer. 2022. PMID: 35912015 Free PMC article. Review.
• Evidence for immortality and autonomy in animal cancer models is often not provided, which causes confusion on key issues of cancer biology.
  Dou X, Tong P, Huang H, Zellmer L, He Y, Jia Q, Zhang D, Peng J, Wang C, Xu N, Liao DJ. Dou X, et al. J Cancer. 2020 Mar 4;11(10):2887-2920. doi: 10.7150/jca.41324. eCollection 2020. J Cancer. 2020. PMID: 32226506 Free PMC article. Review.
• Histone deacetylase 1 activates PU.1 gene transcription through regulating TAF9 deacetylation and transcription factor IID assembly.
  Jian W, Yan B, Huang S, Qiu Y. Jian W, et al. FASEB J. 2017 Sep;31(9):4104-4116. doi: 10.1096/fj.201700022R. Epub 2017 Jun 1. FASEB J. 2017. PMID: 28572446 Free PMC article.
• Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β0-Thalassemia Families with High Fetal Hemoglobin Levels.
  Bianchi N, Cosenza LC, Lampronti I, Finotti A, Breveglieri G, Zuccato C, Fabbri E, Marzaro G, Chilin A, De Angelis G, Borgatti M, Gallucci C, Alfieri C, Ribersani M, Isgrò A, Marziali M, Gaziev J, Morrone A, Sodani P, Lucarelli G, Gambari R, Paciaroni K. Bianchi N, et al. Mol Diagn Ther. 2016 Apr;20(2):161-73. doi: 10.1007/s40291-016-0187-2. Mol Diagn Ther. 2016. PMID: 26897028

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group